Albert Szent-Gy-rgyi, who was simply the recipient of the Nobel Prize for Medicine and Physiology in 1937. Professor Matter receives the award at the Szent-Gy-rgyi Prize Supper and Award Ceremony today at the National Press Club in Washington, DC.. A*STAR’s professor gets Szent-Gy-rgyi prize for groundbreaking cancers pill Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre , has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Analysis by the National Basis for Cancer Study for his contributions to the advancement of the first drug specifically targeting a molecular lesion in malignancy..
Age-related macular degeneration affected person receives investigational eye drops An 88-year-outdated man at The Methodist Hospital in Houston is 1 of 2 patients nowadays to get an investigational eyes drop that might restore sight for those suffering from neovascular age-related macular degeneration, a major cause of central visual reduction and one of the leading factors behind blindness in people over 60 in the usa. Currently, the typical treatment requires multiple injections into the diseased eyes. Today, the individual received the topical administration of the medication known as TG100801 in a Stage IIa, multi-center trial sponsored by TargeGen, Inc. This represents the 1st wet AMD patient in Texas and among the first world-wide to be treated with eye drops by itself for the management of the condition.